| Literature DB >> 35323034 |
Ying Zhou1, Wenxiu Ai2, Yinjuan Guo1, Xiaocui Wu1, Bingjie Wang1, YanLei Xu1, Lulin Rao1, Huilin Zhao1, Xinyi Wang1, Fangyou Yu1.
Abstract
The rapid emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) and the comparatively limited development of new antibiotics pose a major threat to public health. Aminoglycosides are important options that can lower the mortality rate effectively in combination therapy with β-lactam agents. However, in this study, we observed two multidrug-resistant (MDR) K. pneumoniae named 1632 and 1864 that exhibited high-level resistance to both carbapenems and aminoglycosides. Through whole-genome sequencing (WGS), the unusual co-occurrence of rmtB, armA, and blaKPC-2 genes, associating with two key resistance plasmids, was observed in two isolates. Notably, we also found that the armA resistance gene and virulence factor iuc operon co-occurred on the same plasmid in K. pneumoniae 1864. Detailed comparative genetic analysis showed that all these plasmids were recognized as mobilizable plasmids, as they all carry the essential oriT site. Results of conjugation assay indicated that armA-positive plasmids in two isolates could self-transfer to Escherichia coli J53 effectively, especially, the p1864-1 plasmid, which could cotransfer hypervirulent and multidrug-resistant phenotypes to other isolates. Moreover, multiple insertion sequences (ISs) and transposons (Tns) were also found surrounding the vital resistant genes, which could even form a large antibiotic resistance island (ARI) and could stimulate mobilization of resistant determinants. Overall, we report the uncommon coexistence of armA plasmid, rmtB-blaKPC-2 plasmid, and even iuc virulence operon-encoding plasmid in K. pneumoniae isolates, which greatly increased the spread of these high-risk phenotypes and which are of great concern. IMPORTANCE Carbapenemase-producing Klebsiella pneumoniae have become a great challenge for antimicrobial chemotherapy, while aminoglycosides can lower the mortality rate effectively in combination therapy with them. Unfortunately, we isolated two K. pneumoniae from blood sample of patients that not only exhibited high-level resistance to carbapenems and aminoglycosides but also showed the unusual co-occurrence of the rmtB, armA, and blaKPC-2 genes. These elements were all located on mobile plasmids and flanked by polymorphic mobile genetic elements (MGEs). What's worse most, we also identified a conjugative virulent MDR plasmid, coharboring multiple resistant determinants, and iuc operon, which was confirmed could transfer such high-risk phenotype to other isolates. The emergence of such conjugative virulence plasmids may promote the rapid dissemination of virulence-encoding elements among Gram-negative pathogens. This uncommon coexistence of rmtB, armA, blaKPC-2, and iuc virulence operon-encoding plasmids in K. pneumoniae, presents a huge threat to clinical treatment. Future studies are necessary to evaluate the prevalence of such isolates.Entities:
Keywords: K. pneumoniae; armA; blaKCP-2; iuc operon; plasmid; rmtB
Mesh:
Substances:
Year: 2022 PMID: 35323034 PMCID: PMC9045180 DOI: 10.1128/spectrum.02371-21
Source DB: PubMed Journal: Microbiol Spectr ISSN: 2165-0497
Antimicrobial drug susceptibility profiles
| Antibiotics | MIC (mg/L)/antimicrobial susceptibility | ||||
|---|---|---|---|---|---|
| Transconjugants | |||||
| p1632-2-J53 ( | p1864-1-J53 ( | ||||
| MEM | >16/R | >16/R | ≤0.06/S | ≤0.06/S | ≤0.06/S |
| IPM | 16/R | 16/R | ≤0.25/S | ≤0.25/S | ≤0.25/S |
| ETP | >2/R | >2/R | ≤0.015/S | ≤0.015/S | ≤0.015/S |
| GEN | >1024/R | >1024/R | ≤1/S | 1024/R | 1024/R |
| AMK | >1024/R | >1024/R | ≤16/S | 1024/R | 1024/R |
| AMP | >32/R | >32/R | ≤8/S | >32/R | >32/R |
| CZO | >32/R | >32/R | ≤2/S | >32/R | >32/R |
| CAZ | >128/R | >128/R | ≤0.25/S | 1/S | 1/S |
| FEP | >16/R | >16/R | ≤0.5/S | 4/SDD | 8/SDD |
| CSL | >64/32/R | >64/32/R | ≤16/8/S | ≤16/8/S | ≤16/8/S |
| SAM | >32/16/R | >32/16/R | ≤16/4/S | ≤16/4/S | 16/8/I |
| FOX | >32/R | >32/R | ≤8/S | ≤8/S | ≤8/S |
| CXM | >16/R | >16/R | 8/S | >16/R | >16/R |
| CTX | >64/R | >64/R | ≤0.12/S | 32/R | 32/R |
| TZP | >128/4/R | >128/4/R | ≤16/4/S | ≤16/4/S | ≤16/4/S |
| AMC | >32/16/R | >32/16/R | ≤8/4/S | ≤8/4/S | ≤8/4/S |
| LVX | >8/R | >8/R | ≤0.12/S | ≤0.12/S | ≤0.12/S |
| MFX | >2/R | >2/R | ≤0.25/S | ≤0.25/S | ≤0.25/S |
| TCY | ≤2/S | ≤2/S | ≤2/S | ≤2/S | ≤2/S |
| ATM | >16/R | >16/R | ≤4/S | ≤4/S | ≤4/S |
| NIT | >64/R | >64/R | ≤16/S | ≤16/S | ≤16/S |
| SXT | >4/76/R | ≤0.5/9.5/S | ≤0.5/9.5/S | >4/76/R | >4/76/R |
| Caz/AVI | 2/4/S | 2/4/S | ≤0.5/4/S | ≤0.5/4/S | ≤0.5/4/S |
| TGC | 0.5/S | 0.5/S | ≤0.25/S | ≤0.25/S | ≤0.25/S |
MIC, minimal inhibitory concentration; MEM, meropenem; IPM, imipenem; ETP, ertapenem; Caz/AVI, ceftazidime-avibactam; TGC, tigecycline; FOS, fosfomycin; AMP, ampicillin; CZO, cefazolin; CAZ, ceftazidime; FEP, cefepime; CSL, cefoperazone/sulbactam; SAM, ampicillin/sulbactam; FOX, cefoxitin; CXM, cefuroxime; CTX, cefotaxime; TZP, piperacillin-tazobactam; AMC, amoxicillin/clavulanic acid; LVX, levofloxacin; MFX, moxifloxacin; TCY, tetracycline; GEN, gentamicin; AMK, amikacin; ATM, aztreonam; NIT, nitrofurantoin; SXT, trimethoprim/sulfamethoxazole.
General features and antimicrobial resistance genes of plasmids in K. pneumoniae 1632 and 1864
| Characteristics | 1632 | 1864 | ||||||
|---|---|---|---|---|---|---|---|---|
| p1632-1 | p1632-2 | p1632-3 | p1632-4 | p1864-1 | p1864-2 | p1864-3 | p1864-4 | |
| Accension no. |
|
|
|
|
|
|
|
|
| Length (bp) | 163993 | 91703 | 10060 | 5596 | 296908 | 152725 | 43518 | 11970 |
| GC content (%) | 54 | 51 | 55 | 51 | 48 | 55 | 35 | 56 |
| No. of ORF | 209 | 124 | 17 | 12 | 324 | 197 | 63 | 17 |
| Incapability group | IncFII/IncR | IncM2 | ColRNAI | / | IncFIB/IncHIB | IncFII/IncR | / | ColRNAI |
| Conjugal ability | ||||||||
| 34258.0.34343 | 68441.0.68546 | / | / | 125695.0.125722 | 40426.0.40511 | / | / | |
| 153996.0.158669 | 68852.0.70831 | / | / | 46046.0.48994 | / | / | / | |
| 151780.0.153996 | 29046.0.31133 | / | / | 43930.0.46056 | / | / | / | |
| 33691.0.47918 | 70845.0.90445 | / | / | 43930.0.66313 | 39859.0.52106 | / | / | |
| 63667.0.67498 | 212221.0.246796 | |||||||
| 140857.0.160310 | ||||||||
| Resistant genes | ||||||||
|
|
| / | / |
|
| / | / | |
|
|
| / | / |
|
| / | / | |
|
|
| / | / |
|
| / | / | |
|
|
| / | / |
|
| / | / | |
|
| / | / |
|
| / | / | ||
|
| / | / |
|
| / | / | ||
|
| / | / |
|
| / | / | ||
|
| / | / |
| / | / | |||
|
| / | / |
| / | / | |||
|
| ||||||||
| Virulence factors | / | / | / | / |
| / | / | / |
ORF, open reading frame.
/, no such information.
FIG 1Comparative analysis of p1632-1 and p1632-2 plasmids with other reference plasmids. (A) (i) p1632-1 (CP084498) was used as the reference plasmid to perform genome alignment with two IncFII plasmid (harboring rmtB and blaKPC): p1285-KPC (MN842292.1) and pKPC-L388 (CP029225.1). (ii) Comparison of the conjugative system of the reference plasmid pKPHS2 (CP003224.1) and p1632-1. (B) p1632-2 (CP084499) was used as the reference plasmid to perform genome alignment with other IncM2 plasmid pEX18 (LC556221.1) and pCTX-M-3 (AF550415.2). tra, the cluster region of tra protein.
Conjugation frequency of resistant plasmids identified in K. pneumoniae 1632 and 1864
| Plasmid | Resistance gene | No. of independent determinations | Conjugation frequencies | |
|---|---|---|---|---|
| Mean | Range | |||
| p1632-2 |
| 3 | 1.6 × 10−1 | 0.98 × 10−1 to 1.96 × 10−1 |
| p1864-1 |
| 3 | 9.5 × 10−7 | 8.56 × 10−7 to 10.44 × 10−7 |
FIG 2Comparative analysis of rmtB/blaKPC-2 positive p1632-1 and p1864-2 plasmids. (A) Comparison with three IncFII plasmids pl632-1, p1864-2, and reference plasmid pKPHS2. (B) Linear comparison of the rmtB and blaKPC-2 regions of p1632-1 and p1864-2 plasmids. The 16S-RMTase-encoding genes are shown in red, mobile genetic elements are shown in purple, other antimicrobial resistance genes are shown in yellow, and unidentified ORFs are shown in orange. Blue and pink shading indicates nucleotide identity.
FIG 3Comparative analysis of p1864-1 and p1864-2 plasmids with other reference plasmids. (A) Genome alignment was performed with p1864-1 (CP084493) and with another IncFIB virulent plasmid pA1718-HI3 (MW013142.1, iuc operon positive) (B) Genome alignment was performed with p1864-2 (CP084494) and with another IncFII plasmid pHS2953 (MT875328.1).
FIG 4The virulence analysis of p1864-1 plasmid. (A) Siderophore production of K. pneumoniae and E. coli harboring or not harboring iuc-positive plasmid (p1864-1). Hypervirulent K. pneumoniae NTUH-K2044 was used as positive control. (B) Survival rates of G. mellonella infected with E. coli J53 harboring or not harboring iuc-positive plasmid (p1864-1). A log-rank (Mantel-638 Cox) test was performed for the indicated curves. A significant difference (P < 0.0001) was observed between these groups. NS, normal saline.
FIG 5Comparative analysis of armA-positive p1632-2 and p1864-1 plasmids. (A) Comparison with plasmids pl632-2 and p1864-1. (B) Linear comparison of the armA regions of p1632-1 and p1864-2 plasmids. The 16S-RMTase-encoding genes are shown in red, mobile genetic elements are shown in purple, other antimicrobial resistance genes are shown in yellow, other annotated ORFs are shown in blue, and unidentified open reading frames (ORFs) are shown in orange. Blue and pink shading indicates nucleotide identity.
Oligonucleotides for PCR
| Name | Forward/reverse | Sequence |
|---|---|---|
| ArmA | Forward |
|
| Reverse |
| |
| RmtB | Forward |
|
| Reverse |
| |
| KPC-2 | Forward |
|
| Reverse |
|